Sunday, July 24, 2016

BRIEF-RaQualia Pharma says sodium channel blocker patent allowance in China

* Says the company received an allowance for a sodium

channel blocker substance patent in China (Application Number:

201180050306.2, Arylamide derivatives)

Read more
Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)